Enovis (ENOV) Shares Outstanding (2010 - 2026)
Enovis' (ENOV) quarterly Shares Outstanding (Entity) came in at $57.7 million in Q3 2026, up 0.88% year-over-year from $57.2 million in Q3 2025, and little changed quarter-over-quarter from $57.6 million in Q2 2026.
Analysis
Enovis (ENOV) Shares Outstanding (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Shares Outstanding (Entity) for 17 consecutive years, with $57.7 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 0.88% year-over-year to $57.7 million in Q3 2026; TTM through Jul 2026 was $57.7 million, a 0.88% increase from a year earlier, with the FY2025 full-year figure at $57.2 million, up 2.36% from the prior year.
- Shares Outstanding (Entity) was $57.7 million for Q3 2026 at Enovis, roughly flat from $57.6 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $57.7 million in Q3 2026 and troughed at $54.0 million in Q2 2022.
- A 5-year average of $55.6 million and a median of $54.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) climbed 19.54% in 2022 and climbed 0.61% in 2024, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $54.2 million in 2022, then advanced by 0.68% to $54.6 million in 2023, then gained by 2.34% to $55.9 million in 2024, then grew by 2.36% to $57.2 million in 2025, then advanced by 0.82% to $57.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $57.7 million (Q3 2026), $57.6 million (Q2 2026), and $57.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 57.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 57.60 Mn |
| Apr 3, 2026 | 57.31 Mn |
| Dec 31, 2025 | 57.07 Mn |
| Oct 3, 2025 | 57.17 Mn |
| Jul 4, 2025 | 57.13 Mn |
| Apr 4, 2025 | 56.79 Mn |
| Dec 31, 2024 | 55.28 Mn |
| Sep 27, 2024 | 55.67 Mn |
| Jun 28, 2024 | 54.86 Mn |
| Mar 29, 2024 | 54.69 Mn |
| Dec 31, 2023 | 54.49 Mn |
| Sep 29, 2023 | 54.55 Mn |
| Jun 30, 2023 | 54.51 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 54.07 Mn |
| Sep 30, 2022 | 54.14 Mn |
| Jul 1, 2022 | 54.08 Mn |
| Apr 1, 2022 | 53.87 Mn |
| Dec 31, 2021 | 51.14 Mn |
| Oct 1, 2021 | 53.03 Mn |